title: Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesis.
abstract: LHX4 is a member of the LIM-homeobox family and plays a critical role in pituitary development and differentiation. Several lines of evidences have reported their aberrant expression in cancers. However, the exact roles of LHX4 in carcinogenesis remain unclear. In this study, LHX4 expression was analyzed in tumor and paired non-tumor tissues obtained from patients with hepatocellular carcinoma (HCC) using western blotting and immunohistochemistry. LHX4 was found to be downregulated in tumor tissues and negatively correlated with differentiation grade and alpha-fetoprotein (AFP) levels in 66 HCC patients. To clarify the biological functions of LHX4, transient or stable transfectants overexpressing LHX4 were generated in human hepatoma cells (Huh7 and HepG2). LHX4 overexpression in Huh7 and HepG2 cells induced a more differentiated phenotype by reducing AFP expression. Using in silico analysis, the evolutionary conserved region within the AFP promoter containing LHX4-binding site was identified, implying that AFP is a putative target for LHX4. Moreover, ectopic LHX4 overexpression attenuated Huh7 and HepG2 proliferation. Importantly, the growth-inhibitory effect of LHX4 was reversed by replenishing AFP to the LHX4-overexpressing cells, providing a functional relevance between LHX4 and AFP. Finally, we analyzed expressions of LHX4 and AFP during normal liver development. Hepatic LHX4 expression increased in adult liver in a manner that parallel AFP repression. In conclusion, these data indicate that LHX4 may act as a potential tumor suppressor in hepatocarcinogenesis, suggesting that targeting LHX4 to downregulate AFP might have therapeutic implications.
authors.affiliation: Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.
authors.forename: Tzu-Min
authors.initials: TM
authors.lastname: Hung
authors.forename: Rey-Heng
authors.initials: RH
authors.lastname: Hu
authors.forename: Cheng-Maw
authors.initials: CM
authors.lastname: Ho
authors.forename: Ya-Lun
authors.initials: YL
authors.lastname: Chiu
authors.forename: Jia-Ling
authors.initials: JL
authors.lastname: Lee
authors.forename: Yung-Ming
authors.initials: YM
authors.lastname: Jeng
authors.forename: Daniel Tzu-Bi
authors.initials: DT
authors.lastname: Shih
authors.forename: Po-Huang
authors.initials: PH
authors.lastname: Lee
mesh_terms: D000368:Aged; D015153:Blotting, Western; D002471:Cell Transformation, Neoplastic; D015536:Down-Regulation / Q000502:physiology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D060850:LIM-Homeodomain Proteins / Q000502:physiology*; D008113:Liver Neoplasms / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors / Q000502:physiology*; D000509:alpha-Fetoproteins / Q000378:metabolism*
chemical_list: C486362:LHX4 protein, human; D060850:LIM-Homeodomain Proteins; D014157:Transcription Factors; D000509:alpha-Fetoproteins